Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
GLP-1 weight loss drug modulates brain reward circuits and suppresses eating for pleasure
A National Institutes of Health (NIH)-funded study found that an emerging class of GLP-1 weight-loss…
Researchers at Queen Mary University of London have uncovered a previously unknown mechanism by which…
Scientists have discovered new evidence that challenges long-held assumptions about the causes of common types…
Bariatric surgery offers more long-term health protection for older adults than GLP-1 drugs
Metabolic and bariatric surgery provides significantly greater long-term protection against heart attack, stroke, and death…
Metabolic and bariatric surgery results in significantly greater weight loss and improved obesity-related disease remission…
‘We need accountability’: 50 years after dangerous chemical spill, Kansas community demands justice
In northeast Wichita, Kansas, chemicals known to increase the risk of human cancer have been…
Recent research published in JAMA network open We provide evidence that interacting with conversational artificial…
Angus Cheng covers all issues broadly related to cancer, including medicines, policy, science and stocks.…
Novo CEO cites pricing as ‘sweet spot’ as Wegovy pill debuts at $355 million in quarter
Danish pharmaceutical giant Novo Nordisk has received warm feedback on its start-to-2026 performance after several…
In the latest update on the coronavirus and vaccine-related debate heating up at the FDA,…